Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2Active not recruiting 2Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Classical hematology 2Plasma cell 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 78Precursor Cell Lymphoblastic Leukemia-Lymphoma 71Leukemia, Lymphocytic, Chronic, B-Cell 70Myelodysplastic Syndromes 64Hodgkin Disease 63Multiple Myeloma 59Lymphoma, Non-Hodgkin 58Leukemia 53Lymphoma, Follicular 44Lymphoma, Mantle-Cell 43Lymphoma, Large B-Cell, Diffuse 41Lymphoma 41Myeloproliferative Disorders 39Lymphoma, B-Cell, Marginal Zone 37Leukemia, Myelogenous, Chronic, BCR-ABL Positive 37Leukemia, Myeloid, Chronic-Phase 35Congenital Abnormalities 35Burkitt Lymphoma 33Lymphoma, Large-Cell, Immunoblastic 30Leukemia, Myelomonocytic, Chronic 29Leukemia, Myeloid, Accelerated Phase 27Waldenstrom Macroglobulinemia 25Anemia, Refractory, with Excess of Blasts 25Hematologic Neoplasms 23Graft vs Host Disease 21Recurrence 20Dendritic Cell Sarcoma, Interdigitating 20Primary Myelofibrosis 19Lymphoma, T-Cell, Cutaneous 19Blast Crisis 19

Interventions

Cytarabine 9fludarabine 5Imatinib Mesylate 5thymoglobulin 3fludarabine phosphate 3Tacrolimus 3Sirolimus 3Methotrexate 3Cyclophosphamide 3Busulfan 3Azacitidine 3zosuquidar trihydrochloride 2venetoclax 2ponatinib 2nilotinib 2enasidenib 2bosutinib 2RO6839921 2Mycophenolic Acid 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2Behavior Therapy 2Antilymphocyte Serum 24-methyl-N-(3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl)-3-(4-pyrazin-2-ylpyrimidin-2-ylamino)benzamide 2spartalizumab 1sabatolimab 1quizartinib 1plerixafor 1pegfilgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Leukemia, Myeloid × Mycophenolic Acid × Clear all
NCT01760655 2025-10-30

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies

Thomas Jefferson University

Phase 2 Completed
62 enrolled 15 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hodgkin Disease, Leukemia, Myeloid, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Polycythemia Vera, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Primary Myelofibrosis

NCT01392989 2019-05-07

Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

Stanford University

Phase 2 Completed
44 enrolled 13 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Leukemia, Myeloid, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neural Tube Defects

Data powered by HemOnc (CC BY 4.0) Colophon âš¡